DE60141463D1 - Methoden und verbindungen zur hemmung immunoglobulin-vermittelter reperfusions-verletzungen - Google Patents

Methoden und verbindungen zur hemmung immunoglobulin-vermittelter reperfusions-verletzungen

Info

Publication number
DE60141463D1
DE60141463D1 DE60141463T DE60141463T DE60141463D1 DE 60141463 D1 DE60141463 D1 DE 60141463D1 DE 60141463 T DE60141463 T DE 60141463T DE 60141463 T DE60141463 T DE 60141463T DE 60141463 D1 DE60141463 D1 DE 60141463D1
Authority
DE
Germany
Prior art keywords
methods
compounds
immunoglobulin
reperfusion injuries
mediated reperfusion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60141463T
Other languages
English (en)
Inventor
Michael C Carroll
Francis D Moore Jr
Herbert B Hechtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Harvard College
Brigham and Womens Hospital Inc
Immune Disease Institute Inc
Original Assignee
Harvard College
Brigham and Womens Hospital Inc
Immune Disease Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Harvard College, Brigham and Womens Hospital Inc, Immune Disease Institute Inc filed Critical Harvard College
Application granted granted Critical
Publication of DE60141463D1 publication Critical patent/DE60141463D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/52—Constant or Fc region; Isotype
DE60141463T 2000-06-08 2001-06-08 Methoden und verbindungen zur hemmung immunoglobulin-vermittelter reperfusions-verletzungen Expired - Lifetime DE60141463D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US21027200P 2000-06-08 2000-06-08
PCT/US2001/018510 WO2001093892A1 (en) 2000-06-08 2001-06-08 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury

Publications (1)

Publication Number Publication Date
DE60141463D1 true DE60141463D1 (de) 2010-04-15

Family

ID=22782260

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60141463T Expired - Lifetime DE60141463D1 (de) 2000-06-08 2001-06-08 Methoden und verbindungen zur hemmung immunoglobulin-vermittelter reperfusions-verletzungen

Country Status (9)

Country Link
EP (2) EP1286682B1 (de)
JP (1) JP2004502412A (de)
CN (1) CN1443074A (de)
AT (1) ATE459367T1 (de)
AU (1) AU2001275378A1 (de)
CA (1) CA2410458A1 (de)
DE (1) DE60141463D1 (de)
ES (1) ES2343351T3 (de)
WO (1) WO2001093892A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2560066A1 (en) 2004-03-01 2005-09-15 The Cbr Institute For Biomedical Research, Inc. Natural igm antibodies and inhibitors thereof
US20100136684A1 (en) * 2004-03-01 2010-06-03 Carroll Michael C Natural IgM Antibodies
AU2012200909B2 (en) * 2004-03-01 2013-10-03 Immune Disease Institute, Inc Natural lgM antibodies and inhibitors thereof
WO2009035055A1 (ja) * 2007-09-14 2009-03-19 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute インスリン様成長因子-１（ｉｇｆ－１）産生促進剤

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (de) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimäre Rezeptoren durch Verbindung und Expression von DNS
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
JPS61134325A (ja) 1984-12-04 1986-06-21 Teijin Ltd ハイブリツド抗体遺伝子の発現方法
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
JP3771253B2 (ja) 1988-09-02 2006-04-26 ダイアックス コープ． 新規な結合タンパク質の生成と選択
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5530101A (en) 1988-12-28 1996-06-25 Protein Design Labs, Inc. Humanized immunoglobulins
WO1991000906A1 (en) 1989-07-12 1991-01-24 Genetics Institute, Inc. Chimeric and transgenic animals capable of producing human antibodies
AU6886791A (en) 1989-11-13 1991-06-13 Affymax Technologies N.V. Spatially-addressable immobilization of anti-ligands on surfaces
WO1991010741A1 (en) 1990-01-12 1991-07-25 Cell Genesys, Inc. Generation of xenogeneic antibodies
US5427908A (en) 1990-05-01 1995-06-27 Affymax Technologies N.V. Recombinant library screening methods
WO1992020791A1 (en) 1990-07-10 1992-11-26 Cambridge Antibody Technology Limited Methods for producing members of specific binding pairs
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
ES2108048T3 (es) 1990-08-29 1997-12-16 Genpharm Int Produccion y utilizacion de animales inferiores transgenicos capaces de producir anticuerpos heterologos.
DE69133557D1 (de) 1990-08-29 2007-03-15 Pharming Intellectual Pty Bv Homologe rekombination in säugetier-zellen
EP0564531B1 (de) 1990-12-03 1998-03-25 Genentech, Inc. Verfahren zur anreicherung von proteinvarianten mit geänderten bindungseigenschaften
DE69132531T2 (de) 1990-12-06 2001-09-13 Affymetrix Inc Verbindungen und ihre Verwendung in einer binären Synthesestrategie
ES2330052T3 (es) 1991-03-01 2009-12-03 Dyax Corporation Proteina quimerica que comprende micro-proteinas que tienen dos o mas puentes disulfuro y relaizaciones de las mismas.
EP0580737B1 (de) 1991-04-10 2004-06-16 The Scripps Research Institute Bibliotheken heterodimerer rezeptoren mittels phagemiden
DE4122599C2 (de) 1991-07-08 1993-11-11 Deutsches Krebsforsch Phagemid zum Screenen von Antikörpern
WO1993009668A1 (en) 1991-11-22 1993-05-27 Affymax Technology N.V. Combinatorial strategies for polymer synthesis
US5233409A (en) 1992-02-25 1993-08-03 Schwab Karl W Color analysis of organic constituents in sedimentary rocks for thermal maturity
US5359115A (en) 1992-03-26 1994-10-25 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5573905A (en) 1992-03-30 1996-11-12 The Scripps Research Institute Encoded combinatorial chemical libraries
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
CA2143848C (en) 1992-10-01 2007-09-11 W. Clark Still Complex combinatorial chemical libraries encoded with tags
EP0714409A1 (de) 1993-06-16 1996-06-05 Celltech Therapeutics Limited Antikoerper
US5362899A (en) 1993-09-09 1994-11-08 Affymax Technologies, N.V. Chiral synthesis of alpha-aminophosponic acids
WO1996036360A1 (en) * 1995-05-17 1996-11-21 Regents Of The University Of Minnesota Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies
IT1395574B1 (it) 2009-09-14 2012-10-16 Guala Dispensing Spa Dispositivo di erogazione

Also Published As

Publication number Publication date
AU2001275378A1 (en) 2001-12-17
EP2251026A1 (de) 2010-11-17
EP1286682A1 (de) 2003-03-05
ES2343351T3 (es) 2010-07-29
WO2001093892A1 (en) 2001-12-13
CA2410458A1 (en) 2001-12-13
JP2004502412A (ja) 2004-01-29
ATE459367T1 (de) 2010-03-15
EP1286682B1 (de) 2010-03-03
EP1286682A4 (de) 2004-10-13
CN1443074A (zh) 2003-09-17

Similar Documents

Publication Publication Date Title
DE69429208T2 (de) Substanz P Antagonisten zur Behandlung von Erbrechen
DE60236622D1 (de) Formmasse für ozonbeständige gegenstände und ozonbeständige spritzgegossene gegenstände
ATE448791T1 (de) Methoden und zusammensetzungen für die behandlung von glomerulonephritis
DE60321965D1 (de) Amidfunktionelle polymere, zusammensetzungen und verfahren
DE69827127D1 (de) Mehrwertige impstoffzusammensetzung mit gemischten trägern
DE69715802D1 (de) Quantentopf-mos-transistor und verfahren zur herstellung
ATE271749T1 (de) Vorrichtung und verfahren zum warmhalten von speisen
ATE360884T1 (de) Vorrichtung zum behandeln eines scheibenförmigen gegenstandes
PT1944371E (pt) Antigénios e composições da neisseria meningitidis
PT842934E (pt) Agonistas de 5-ht1f
DE69417199T2 (de) LC-Element, Halbleiteranordnung, und Verfahren zur Herstellung des LC-Elements
DE60141463D1 (de) Methoden und verbindungen zur hemmung immunoglobulin-vermittelter reperfusions-verletzungen
ATE278441T1 (de) Verfahren zum auffinden von verbindungen, welche zur behandlung und/oder prophylaxe von obesitas geeignet sind
DE68916182T2 (de) Halbleitereinrichtung, z.B. Feldeffekttransistor, und Verfahren zur Herstellung derselben.
DE60135349D1 (de) Heisssiegelbare polyolefine
DE69504621T2 (de) Methoden zur Wärmebehandlung von Halbleitermaterial aus Verbindungen der Gruppen III-V
NO20002408D0 (no) 5-HT1F antagonister
ATE163036T1 (de) Waschmittelzusammensetzungen zur verhinderung der farbstoffübertragung
DE60136729D1 (de) Behandlung von textilmaterialien mit polyorganosiloxanen
DE657918T1 (de) Verfahren und Vorrichtung zum Einbrennen und Kühlen von Halbleiterscheiben und dergleichen.
ATE421978T1 (de) Verfahren zur erhöhung der schmelzefestigkeit von polypropylen
DE50009654D1 (de) Maschine und Verfahren zum automatischen Stapeln von Stapelgut, wie z. B. Steigen, Kisten odgl.
DE60211153D1 (de) Verbesserte entfernung von flüchtigen stoffen beim festphasenhärten-verfahren von nylon-6 bei temperaturprogrammierung
DE602005006649D1 (de) Verfahren zur Behandlung von Keksen durch Strahlungsheizung
DE59905386D1 (de) Vorrichtung zum durchströmenden, kontinuierlichen Behandeln von Textilgut o. dgl.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition